Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

Rhea-AI Summary

Aytu BioPharma (Nasdaq: AYTU), a pharmaceutical company focused on innovative medicines for complex central nervous system diseases, will participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026.

The virtual webcast begins at 9:15 a.m. ET, with replay available on the conference site and Aytu’s investor relations webpage. Management will also host virtual one-on-one meetings with investors during the event.

News Market Reaction – AYTU

-0.95%

-0.95% Session close to close

In the May 19 session, AYTU declined 0.95%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Aytu BioPharma’s participation in a virtual investor conference on May ...

Analysis

This announcement highlights Aytu BioPharma’s participation in a virtual investor conference on May 28, 2026, including a webcast at 9:15 a.m. Eastern and one-on-one meetings. In recent months, the company has reported declining revenue and net losses while launching EXXUA and repositioning around CNS medicines. Investors may focus on how management uses this forum to clarify growth plans, commercialization progress, and balance-sheet flexibility following recent quarterly and regulatory disclosures.

Key Figures

Conference date: May 28, 2026 Webcast time: 9:15 a.m. Eastern

2 metrics

Conference date May 28, 2026 Lytham Partners Spring 2026 Investor Conference

Webcast time 9:15 a.m. Eastern Scheduled start time for AYTU conference webcast

Historical Context

5 past events · Latest: May 13 (Negative)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 13	Earnings results	Negative	+0.9%	Reported fiscal 2026 Q3 revenue decline and net loss with EXXUA launch ramp.
May 6	Earnings date announcement	Neutral	-3.5%	Scheduled Q3 fiscal 2026 results release and accompanying call and webcast.
Feb 3	Earnings results	Negative	-10.3%	Reported Q2 fiscal 2026 revenue decline, net loss and initial EXXUA launch metrics.
Jan 27	Earnings date announcement	Neutral	+0.8%	Announced timing and access details for Q2 fiscal 2026 results call.
Jan 20	Investor day recap	Positive	-2.6%	Showcased EXXUA Phase 3 data, MDD market size and commercialization economics.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Earnings releases tend to drive clearer price alignment, while investor-focused communications (dates, events, recaps) often see smaller or divergent moves.

Recent Company History

Over the last six months, AYTU’s key news centered on financial results and the EXXUA launch. Fiscal 2026 Q2 and Q3 earnings showed declining revenue and net losses, with mixed price reactions. Earnings date announcements on Jan 27 and May 6 mainly served as scheduling updates. The Jan 20 Investor Day recap highlighted EXXUA’s Phase 3 data and commercialization opportunity but was followed by a modest negative move. Today’s conference participation notice fits into this pattern of ongoing investor outreach around the CNS-focused strategy.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DENVER, CO / ACCESS Newswire / May 18, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026.

Company Webcast

The webcast presentation will take place at 9:15 a.m. Eastern time on Thursday, May 28, 2026. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2026/ or directly at https://app.webinar.net/8p9EoXv752z. The webcast will also be available for replay following the event. It will also be accessible on the Investors section of the Company's website at https://investors.aytubio.com/ under Events & Presentations.

1x1 Meetings

Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/spring2026invreg/.

About Aytu BioPharma

Aytu is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. The Company's prescription products include EXXUA^™ (gepirone) extended-release tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of major depressive disorder (MDD), and treatments for attention deficit-hyperactivity disorder (ADHD). Aytu is committed to delivering the Company's medications through best-in-class patient access programs that help to enable optimal patient outcomes. For more information, please visit aytubio.com or follow us on LinkedIn.

Contacts for Investors

Ryan Selhorn, Chief Financial Officer
Aytu BioPharma, Inc.
rselhorn@aytubio.com

Robert Blum
Lytham Partners
aytu@lythampartners.com

SOURCE: Aytu BioPharma, Inc.

View the original press release on ACCESS Newswire

FAQ

When will Aytu BioPharma (AYTU) present at the Lytham Partners Spring 2026 Investor Conference?

Aytu BioPharma will present via webcast on Thursday, May 28, 2026 at 9:15 a.m. Eastern time. According to the company, the presentation is part of the virtual Lytham Partners Spring 2026 Investor Conference.

How can investors access the Aytu BioPharma (AYTU) webcast for the May 28, 2026 Lytham conference?

Investors can access the webcast through the conference home page or the direct webinar link provided. According to Aytu BioPharma, a replay will also be available on the company’s Investors & Presentations webpage.

Will a replay of Aytu BioPharma’s (AYTU) May 28, 2026 Lytham conference webcast be available?

Yes, the webcast will be available for replay following the event. According to Aytu BioPharma, investors can view the replay via the conference website and the company’s investor relations section under Events & Presentations.

How can investors schedule one-on-one meetings with Aytu BioPharma (AYTU) at the Lytham Partners Spring 2026 conference?

Investors can request virtual one-on-one meetings by contacting Lytham Partners at the provided email address. According to Aytu BioPharma, investors may also register for the event through the Lytham conference registration link.

What type of company is Aytu BioPharma (AYTU) presenting at the Lytham Partners Spring 2026 Investor Conference?

Aytu BioPharma is a pharmaceutical company focused on innovative medicines for complex central nervous system diseases. According to the company, its goal is to improve quality of life for patients through these targeted therapies.